Skip to main content
METabolic EXplorer logo

METabolic EXplorer — Investor Relations & Filings

Ticker · METEX ISIN · FR0004177046 LEI · 969500VI1GSBPGD9B460 PA Manufacturing
Open in API
Filings indexed 524 across all filing types
Latest filing 2024-07-16 Legal Proceedings Report
Country FR France
Listing PA METEX

About METabolic EXplorer

https://www.metabolic-explorer.com/

METabolic EXplorer (METEX) is an industrial biotechnology company specializing in the development and industrialization of fermentation bioprocesses. The company produces functional ingredients and chemical intermediates from renewable, non-food raw materials, offering sustainable alternatives to petrochemical processes. Its portfolio is centered on three main product families: 1,3-propanediol (PDO) for cosmetics, liquid polymers, and textiles; butyric acid (BA) for animal nutrition and the flavors and fragrances market; and amino acids for animal feed. The company operates through its subsidiaries, METEX NØØVISTA, which manages the PDO and BA production, and METEX NØØVISTAGO, which focuses on amino acids and ingredients for animal nutrition.

Recent filings

Filing Released Lang Actions
Conversion en liquidation judiciaire des procédures de redressement judiciaire ouvertes au bénéfice de METEX NØØVISTAGO et de METabolic EXplorer
Legal Proceedings Report Classification · 1% confidence The document is a press release dated July 16, 2024, announcing that the Paris Commercial Court ordered the conversion of the judicial reorganization procedures for METEX NØØVISTAGO and METabolic EXplorer into judicial liquidation. It also mentions the delisting of the shares. This type of announcement, detailing significant legal/financial restructuring events (liquidation, delisting implications) that are not standard periodic reports (10-K, IR) or specific financing events (CAP), falls best under the general category for regulatory announcements that don't fit elsewhere, which is Regulatory Filings (RNS). While it mentions delisting, it is an announcement *about* the court decision, not the formal delisting notice itself (DLST). It is a significant, non-standard corporate event disclosure.
2024-07-16 French
Avril désignée repreneur des activités de METEX NØØVISTAGO et d'une partie des activités de METabolic EXplorer par le Tribunal de commerce
Delisting Announcement Classification · 1% confidence The document is a press release dated July 12, 2024, announcing a significant corporate event: the Paris Commercial Court designating Avril as the purchaser (repreneur) for the activities of METEX NØØVISTAGO and parts of METabolic EXplorer following insolvency proceedings (redressement judiciaire/sauvegarde). This announcement details the outcome of a legal/financial restructuring process and its impact on shareholders (delisting, no payout). This type of announcement, which is a formal communication about a major corporate action or legal proceeding outcome, fits best under 'Regulatory Filings' (RNS) as it is a general regulatory announcement that doesn't specifically match the definitions for ER, CT, CAP, or LTR, although it relates to legal proceedings. Since it is a press release announcing a court decision regarding the company's structure, RNS is the most appropriate general regulatory category, as it is not a full financial report (10-K, IR) or a specific management/board change (MANG).
2024-07-12 French
Examen de l'offre de reprise en plan de cession des activités de METEX NØØVISTAGO et d'une partie des activités de METabolic EXplorer
Legal Proceedings Report Classification · 1% confidence The document is a press release dated July 1, 2024, from METabolic EXplorer (METEX) announcing that the Paris Commercial Court examined a takeover offer for its subsidiaries (METEX NØØVISTAGO and METabolic EXplorer) and ordered the conversion of the judicial reorganization proceedings into judicial liquidation for METEX NØØVISTA. This announcement concerns significant legal proceedings, restructuring, and potential delisting/share value nullification. It is not a full Annual Report (10-K), an Interim Report (IR), an Earnings Release (ER), or a formal proxy statement (DEF 14A/PSI). Since it details significant legal and restructuring events, it fits best under Legal Proceedings Report (LTR) or potentially a general Regulatory Filing (RNS). Given the focus on the court's examination of the takeover offer and the conversion to liquidation, LTR is highly relevant, but as it is a general announcement about court proceedings and restructuring outcomes, it also functions as a broad regulatory disclosure. Since LTR specifically covers 'significant lawsuits, regulatory actions, or legal matters,' and this involves court-mandated restructuring and liquidation, LTR is the most precise fit among the specific categories. However, the document structure strongly resembles a standard press release announcing a major corporate event that impacts the company's structure and stock listing, which often falls under general regulatory announcements if a more specific category like 'Delisting Announcement' (DLST) or 'Capital/Financing Update' (CAP) isn't perfectly met. The core event is the court's decision regarding the restructuring/takeover, which is a legal matter. I will classify it as LTR due to the explicit mention of court proceedings, restructuring, and potential delisting consequences stemming from legal actions.
2024-07-01 French
MAASH désignée repreneur des actifs et des activités de METEX NØØVISTA par le Tribunal de commerce
Legal Proceedings Report Classification · 1% confidence The document is a press release dated June 26, 2024, announcing a significant corporate event: the designation of MAASH as the successful bidder (repreneur) for the assets and activities of the subsidiary METEX NØØVISTA by the Commercial Court (Tribunal de commerce) following insolvency proceedings (redressement judiciaire). This type of announcement, detailing legal proceedings, restructuring, and the outcome of court decisions regarding business continuity or failure, fits best under the category of Legal Proceedings Report (LTR) or potentially a general Regulatory Filing (RNS) if LTR is too narrow. Since it specifically details the outcome of a legal/judicial process concerning the company's operations and assets, LTR is the most precise fit among the provided options, as it relates to significant lawsuits or regulatory/judicial actions. It is not an ER (only highlights), 10-K/IR (not a full financial report), CT (not a transcript), or DIV/CAP/SHA/POS (not related to dividends, financing, or share issuance). It is an announcement about a legal/judicial event, making LTR appropriate.
2024-06-26 French
Conversion de la procédure de sauvegarde ouverte au bénéfice de METabolic EXplorer en procédure de redressement judiciaire
Legal Proceedings Report Classification · 1% confidence The document is a press release dated June 12, 2024, announcing that the Paris Commercial Court converted the company's 'procédure de sauvegarde' (safeguard procedure) into a 'procédure de redressement judiciaire' (reorganization/insolvency proceeding). This type of announcement, detailing significant legal and financial restructuring events (like conversion to judicial reorganization, setting deadlines for takeover bids, and noting the suspension of trading), does not fit neatly into the specific financial reporting categories (10-K, IR, ER, etc.). It is a critical, non-standard regulatory update concerning the company's legal status and potential asset sales. Since it is a specific legal/financial event announcement that isn't covered by other specific codes (like M&A (TAR) or Capital Change (CAP)), the most appropriate fallback category is Regulatory Filings (RNS), which covers general regulatory announcements.
2024-06-12 French
Réception d'une offre de reprise portant sur les activités de METEX NØØVISTAGO et une partie des activités commerciales et RetD de METabolic EXplorer
Legal Proceedings Report Classification · 1% confidence The document is a press release dated June 3, 2024, detailing significant corporate events related to restructuring, judicial proceedings (redressement judiciaire/sauvegarde), and the receipt of a takeover bid ('offre de reprise') from Avril concerning the company's assets (METEX NØØVISTAGO and parts of METabolic EXplorer). It discusses the examination of this offer by the Commercial Court of Paris and mentions the potential liquidation of the entities if the sale does not proceed as planned. This content strongly relates to major corporate restructuring, potential asset sales, and legal/financial distress proceedings. This type of announcement, which is not a standard periodic financial report (10-K, IR, ER) or a specific shareholder action (AGM, DIV), falls best under the category of major corporate activity announcements. Since it involves a takeover/asset sale proposal within a judicial context, it aligns closely with 'M&A Activity' (TAR) or, given the context of judicial proceedings and restructuring, it could be considered a significant regulatory/corporate event. However, the core subject is the receipt and examination of a takeover offer for assets, which is the definition of M&A Activity (TAR). It is a formal announcement, not a full report, but the subject matter is specific enough to avoid the general 'RNS' fallback.
2024-06-03 French

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.